DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer

Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer

(2013) Daniel P. Nguyen et al.   BJU INTERNATIONAL

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer

(2013) Melina-Theoni Gyparaki et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression

(2012) P McCall et al.   BRITISH JOURNAL OF CANCER

Global Methylation Profiling for Risk Prediction of Prostate Cancer

(2012) S. Mahapatra et al.   CLINICAL CANCER RESEARCH

Targeting the Unique Methylation Pattern of Androgen Receptor (AR) Promoter in Prostate Stem/Progenitor Cells with 5-Aza-2′-deoxycytidine (5-AZA) Leads to Suppressed Prostate Tumorigenesis

(2012) Jing Tian et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Activation of Nuclear Factor κB (NF-κB) in Prostate Cancer Is Mediated by Protein Kinase C ϵ (PKCϵ)

(2012) Rachana Garg et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Toward the Detection of Prostate Cancer in Urine: A Critical Analysis

(2012) Matthew Truong et al.   JOURNAL OF UROLOGY

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

(2012) Christopher E Barbieri et al.   NATURE GENETICS

Epigenetics in Prostate Cancer: Biologic and Clinical Relevance

(2011) Carmen Jerónimo et al.   EUROPEAN UROLOGY

Aberrant Promoter Methylation of DLEC1, a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage

(2010) Qian Zhang et al.   JOURNAL OF UROLOGY

NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth

(2009) Liying Zhang et al.   AMERICAN JOURNAL OF PATHOLOGY

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers

(2009) J Ying et al.   BRITISH JOURNAL OF CANCER

DNA methylation changes in prostate cancer: current developments and future clinical implementation

(2009) Mohammad Obaidul Hoque   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma

(2008) T J Seng et al.   BRITISH JOURNAL OF CANCER

The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle

(2008) Guo-Hua Qiu et al.   JOURNAL OF HEPATOLOGY